Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Sensei Biotherapeutics, Inc. SNSE

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 16, 2026 8-K 4 signals fired
Other
Director Continuity Stated Severance Payment Obligation Executive Severance Change Of Control
Core
Management Exodus
Mar 30, 2026 10-K 130 signals fired · top 15
Other
Restructuring Charge Disclosed Net Loss Reported Capital Raising Uncertainty Disclosed Warrant Valued Black Scholes Patent Family Portfolio Disclosure Codm Segment Reporting Disclosure Reverse Stock Split Effected Competition Disclosure Share Withholding Tax Settlement Effective Tax Rate Reconciliation Cash Flow Statement Investing Activities Deferred Tax Asset Valuation Disclosure New York Jurisdiction Clause Confidential Information Return Obligation
Core
Regulatory Designation Only
Mar 30, 2026 8-K 10 signals fired
Other
Net Loss Reported Administrative Efficiency Kol Endorsement Personnel Cost Decrease Disclosure Burn Rate Controlled Interim Data Positive
Core
Lead Asset Progress Clinical Hold Indication Expansion Combination Therapy Mentioned
Feb 18, 2026 8-K 55 signals fired · top 15
Other
Executive Educational Background Disclosure Corporate Organization And Standing Representation Amendment Modification Waiver Clause Indemnification Consent Requirement Rsu Psu Vesting Schedule Disclosed Corporate Authority Representation Earnings Call Replay Details Fcpa Compliance Representation Earnings Call Qa Segment Nyse Listing Disclosure Interim Data Positive Sanctions Compliance Representation Merger Subsidiary Creation
Core
Clinical Trial Result Combination Therapy Mentioned
Feb 13, 2026 8-K 4 signals fired
Other
Executive Educational Background Disclosure Classified Board Director Election Successor Agent Appointment Provision Power Of Attorney Disclosure
Nov 14, 2025 10-Q 50 signals fired · top 15
Other
Executive Educational Background Disclosure Net Loss Reported Warrant Valued Black Scholes Capital Raising Uncertainty Disclosed Personnel Cost Decrease Disclosure Depreciation Expense Composition Disclosure Financing Activities Cash Flow Disclosure Cash Flow Statement Investing Activities Amendment Modification Waiver Clause Shares Outstanding Disclosure Diversity Equity Inclusion Commitment Liquidity Position Snapshot Disclosed Competition Disclosure
Core
Clinical Trial Result Management Exodus
Nov 14, 2025 8-K 6 signals fired
Other
Net Loss Reported Administrative Efficiency Burn Rate Controlled Personnel Cost Decrease Disclosure Workforce Reduction Restructuring Plan
Healthcare
Utilization Improving
Oct 30, 2025 8-K 1 signal fired
Other
Workforce Reduction Restructuring Plan